Press Releases
2020
Allterum Granted Two Designations by the FDA
Salivary IgA antibodies against SARS-CoV-2
Brevitest becomes first remote resident of LaunchPort™
Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19
Allterum closes $2.9 million CPRIT award and initiates drug manufacturing scale-up with FujiFilm Diosynth
Pulmotect Shows Promising Pre-Clinical Efficacy in Preventing Lethal Coronavirus Infection
2019
Fannin Attracts Experienced Financier/MD to Houston
Chorioanchor Awarded SBIR Grant from NIH
Brevitest Awarded SBIR Phase II Grant from NIDA
Dr. Colin Broom Joins Pulmotect Inc. as Chief Executive Officer
Think Houston, think India, think biomedical innovation [Opinion]
Pulmotect Announces Election of Dr. Kumar Srinivasan
Fannin Awarded NIH Grant For Atrapos
Houston Chronicle-Procyrion passes key FDA milestone
Ten New Fellows Join Fannin’s Fellowship Program
Procyrion Receives FDA Breakthrough
Fannin Closes $5.25 Million Fundraising Round
Procyrion Closes Series ‘D’
2018
Elizabeth Hoff Joins Fannin – HBJ
Fannin Fellows Promoted
Elizabeth Hoff Joins Fannin
Pulmotect Closes Series ‘B’
ChorioAnchor Receives NIH Grant
Acelerox Receives CPRIT Award
Fannin Receives 3rd SBA Award
2017
Fannin Hires New Fellows
Acelerox Receives NIH Award for Alzheimer’s
Stent-X Receives NIH Award
Fannin’s Atrapos Wins NIH Award for Eczema
Fannin’s rHDL Wins NIH Award for Cancer Research
Fannin’s Exotect Wins NIH Award for Lung Disease Research
Fannin Wins SBA Tibbetts Award
2016
Melissa Singh Named Principal
GuidaBot Wins NSF Grant
Fannin Wins SBA Award
Fannin Renovates and Expands Offices
BreviTest Wins Award for Cannabis Testing
Pulmotect Completes Second Clinical Trial
Fannin Hires New Fellows
2015
Fannin Hires 2015 Fellows
Pulmotect Wins $3MM Grant
Fannin’s Atul Varadhachary Appointed to Health Care Advisory Board
Fannin Forms Acelerox
Fannin Forms GuidaBot
Fannin Closes $7.3MM Round
BreviTest Wins Award for Ultra-Fast Diagnostic Device
2014
BreviTest Wins Goradia Innovation Prize
Pulmotect Completes First Clinical Trial